International Stem Cell Corp., a biotechnology company
developing novel stem cell-based therapies, announced that its scientific team
has developed a robust innovative technology to generate functional articular
cartilage from the patient’s own skin or adipose tissue to treat
osteoarthritis. ISCO believes this technology may allow the company to provide
relief to patients suffering from osteoarthritic knee joints, as well as to
those with shoulder joints and intervertebral spinal disk osteoarthritis.
Ruslan Semechkin, ISCO’s chief scientific officer, stated,
“While we are working on obtaining regulatory approval for the Parkinson’s
disease treatment in Australia, as well as in the US, we are also pursuing a
number of other therapeutic indications including osteoarthritis, which can
potentially be treated with the patient’s own cells.”
Even though osteoarthritis is prevalent in our society,
there is a lack of an effective treatment for this disease. Developing and
successfully testing a scalable system that permits the generation of
functional human cartilage tissue with superior mechanical properties is a
significant accomplishment. The capacity to provide greater stability than
other tissue that is currently available for the treatment of osteoarthritis is
even more impressive.
Osteoarthritis is a degenerative joint disease characterized
by progressive erosion of the articular cartilage. Although osteoarthritis can
damage any joint in the body, the disorder most commonly affects joints in the
hands, knees, hips and spine. The erosion of articular cartilage leads to joint
pain, stiffness, and impaired mobility. According to the Arthritis foundation
osteoarthritis affects over 27 million Americans with an estimated medical
costs of as much as $65 billion.
For more information on the company, visit
www.internationalstemcell.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
